Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for hidden arthritis: drug trial targets pain without X-Ray signs

NCT ID NCT07339566

Not yet recruiting Disease control Sponsor: Lingli Dong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a drug called xeligekimab in 40 adults with non-radiographic axial spondyloarthritis, a form of arthritis that causes back pain but doesn't appear on X-rays. Participants receive six injections over 12 weeks, and doctors check if symptoms improve by at least 20%. After 12 weeks, patients may continue the drug but must pay for it themselves. The goal is to control disease activity, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NR-AXIAL SPONDYLOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Non-Radiographic Axial Spondyloarthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-RADIOGRAPHICAL AXIAL SPONDYLOARTHRITIS NR-AXIAL SPONDYLOARTHRITIS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, 430000, China

    Contact